paracetamol, salicylates, and other non-steroidal antiinflammatory drugs (NSAIDs), and non-acidic pyrazolone derivatives-for example, dipyrone (metamizole) and phenazone (antipyrine); aminophenazone (aminopyrine) has been withdrawn from the market.5 As a group, they share analgesic, antipyretic, and, to a greater or lesser extent, antiinflammatory properties.2 Conversely, these compounds show marked differences in their therapeutic action and side effects.5 Their common denominator was thus believed to be their site of action within the damaged tissues,6 and hence they were termed 'peripheral analgesics'.
This assumption was mainly based on the following findings. Firstly, the classic cross-circulation experiment performed in the dog by Lim et alP indicated that the analgesic effect of aspirin-like drugs occurred in the pain producing site itself rather than in the central nervous system. Secondly, injections of minute amounts of acetylsalicylic acid, indomethacin, or paracetamol into the inflamed paws of rats were shown to attenuate the nociceptive responses.8 Moreover, NSAIDs may alter perceived pain intensity in rodents when applied locally to the injured sites.9 1 In humans too, locally applied aspirin and paracetamol appeared to be effective for controlling pain in the early postoperative period after third molar surgery.1" Thirdly, pharmacokinetic data are consistent with the peripheral activity of these drugs.5 12 Systemically administered NSAIDs were found to achieve particularly high concentrations in their target tissues in animals5 as well as in humans. 13 '4 Finally, the analgesic property of aspirin-like drugs might be ascribed to their ability to inhibit prostaglandin biosynthesis.6 15 Indeed any tissue damage related to trauma, ischaemia, hyperthermia, or inflammation results in the release of various chemical substances, including prostaglandins, which may sensitise the primary afferent nociceptors to pain mediators, such as bradykinin. 16 However, this mechanism ofaction has been questioned. 17 18 Furthermore, experimental and clinical studies support the possibility of an additional central component in the analgesic action of aspirin-like drugs. This paper aims at reviewing these challenging findings.
Centrally mediated analgesic effect of aspirin-like drugs The central analgesic effect of aspirin-like drugs can be directly assessed by injecting them into the central nervous system in various in vivo models of acute pain. In this way very low doses of indomethacin or acetylsalicylic acid or paracetamol influenced in a dose-related manner the hyperalgesia associated with intraplantar injections of carrageenin into the rat paws.8 The potency of intraventricular aspirin was estimated to be about 50 times greater than that after the intraperitoneal dosing in the tooth pulp stimulation test in conscious monkeys. ' 25 Whether systemically administered aspirin-like drugs too produce a central analgesic effect has now to be ascertained. It was assumed that non-narcotic analgesics merely act in those areas in which they achieve high concentrations.5 Accordingly, several NSAIDs and paracetamol were found to cross rapidly the blood-brain barrier in animals26 27 and in humans.2-30 Equilibrium was reached within a few hours and their cerebrospinal fluid concentrations were close to their free plasma concentrations.28 Experimental assays provided further indirect evidence of a central impact of these compounds. Some of them23 31 were active in animal models of acute pain that are usually considered as specifically responsive to the opiates. 23 34 the lack of effect of acetylsalicylic acid may be explained by the poor permeability of the blood-brain barrier to very low lipophilic molecules.28 This does not preclude, however, the possibility of a central analgesic action of salicylates. Higher doses may promote the diffusion of salicylates into the central nervous system by increasing their free fraction in the plasma. 28 Most of these studies suggest that aspirin-like drugs exert a direct analgesic effect at some levels of the neuraxis, as do other kinds of non-narcotic analgesics, such as nefopam and flupirtine.38 As opiates were shown to exert a peripheral analgesic action in addition to their well known central effects,39 a clear cut discrimination between peripheral and central analgesics is debatable. The peripheral analgesic activity of aspirin-like drugs is not disproved, however. The analgesia produced by both peripheral and central mechanisms may be additive, or even synergistic.8 The relative contribution of each site of action to the overall analgesia remains to be established8 20 46 Similarly, the depressive effect ofintravenous administration of aspirin on the firing discharge of thalamic neurones elicited by noxious stimuli in rats was counteracted by pretreating the animals with a serotonin receptor antagonist. 47 The activation of the descending serotoninergic inhibitory pathway may also account for the analgesic effect of paracetamol.48 Interestingly, naloxone did not alter the central effects of aspirin-like drugs, indicating that endogenous opioids are not implicated in these processes.45 47 48 Although alternative mechanisms have been proposed, such as an increase in pituitary j3 endorphin secretion49 or a direct effect on the neurone membrane potential,37 monoamine systems appear to play an important part in the central analgesic effect of aspirin-like drugs. Whether this mechanism may be linked to prostaglandin biosynthesis inhibition will now be discussed.
Central analgesic effect and prostaglandin inhibition Aspirin-like drugs are well known inhibitors of prostaglandin synthetases of different tissue origins. Whether paracetamol impedes cyclo-oxygenase activity in the central nervous system selectively is debated.'5 50 Salicylic acid, which is generally considered as a poor cyclo-oxygenase inhibitor on the basis of in vitro data, was found to be as potent as aspirin in preventing prostaglandin production in inflammatory exudates in vivo. 5 
